AstraZeneca Says Its Oxford Vaccine Deal Allows It To Add Up To 20% Of Manufacturing Costs

AstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be incurred by the British drugmaker.

from Top Business News- News18.com https://ift.tt/3krixDv

• Tweet
• Share
• Share
• Share
• Share